The properties of graphene oxide (GO) have received attention and applied to explore potential applications in disease-related diagnostics and non-invasive therapy. As one of them photodynamic therapy (PDT) kills cancer...
The introduction of nonfullerene acceptors (NFAs) has pushed the power conversion efficiency and organic photovoltaics (OPV) device stability to new standards. In this aspect, removal of trace impurities from one purification stage to the next is frequently stressed throughout the synthesis of photoactive OPV materials and NFAs to obtain the highest‐purity material. However, detailed studies of the effect of purification on device performance are less reported. Herein, the role of NFA trace impurities on the optoelectronic characteristics and lifetime of resulting OPV devices is studied. The optimization of PBDB‐T:ITIC‐X devices, with various ITIC purity levels (X), has been thoroughly studied via a combination of photophysical, chemical, morphological, electrical, and optical characterization techniques, to shine light on the role of these impurities on device performance and lifetime. The findings suggest that, even in materials with larger concentrations of trace impurities, careful tuning can produce high efficiencies. Interestingly, the less‐pure materials lead to longer device lifetimes along with an enhancement in accumulative power generation by a factor 3, compared to the purest ITIC‐based devices. This demonstrates that selecting a material with the highest purity may not always be the best option for NFA OPV and that any positive effects of NFA purification must be carefully considered in light of both the device efficiency and stability.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.